Background: Sexual health is an important component of general health. Objective: To evaluate sexual function and sexual quality of life (SQOL) in women during the COVID-19 pandemic. Methods: This descriptive, cross-sectional study was conducted in Turkey. Data were collected via a Visual Analog Scale (VAS), Female Sexual Function Index (FSFI), and Sexual Quality of Life–Female (SQOL-F) questionnaire. Results: The mean FSFI score was 26.91±5.62, and 39.1% of the women had an FSFI score of 26.55 or lower. The mean SQOL-F score was 79.08±20.90. FSFI score was significantly associated with employment status (β=-0.661), partner education (β=1.698), sexual compatibility between partners (β=0.518), sexual satisfaction (β=0.230), fatigue level (β= -0.120), and frequency of sexual intercourse (β=0.160). In addition, SQOL-F score was significantly associated with sexual desire (β=2.625), satisfaction (β=1.338), pain or discomfort (β=1.274), age (β= -0.356), sexual compatibility between partners (β=1.984), and fatiguelevel (β=-0.981) (p<0.05). Conclusion: Less than half of the women participating in this study had sexual dysfunction, and overall SQOL was moderate to high. These results were associated with some descriptive characteristics of the women and were similar to those reported in pre-pandemic studies conducted in Turkey. Keywords: COVID-19; quality of sex life; sexuality; sexual function; women.

Sonuç: DA hastalarının farklı polikliniklere başvurması nedeniyle takip süreçleri kontrol edilememektdir. DA yarası olan hastaların sabit bir poliklinikten girişlerinin yapılması, tedavi süreçlerinin ve takiplerinin buradan yönetilmesi ile süreçler kontrol edilebilecek, multidisipliner olarak hastaların değerlendirilmesi ve tedavi uygulamaları ile de ekstremite koruyucu tedavi başarı oranınının artması yanında maliyette azalma sağlanacaktır.